Hemab Therapeutics Holdings, Inc. · NASDAQ:COAG
Hemab Therapeutics Holdings, Inc. shareholders
As of Jun 30, 2026, 52 institutions reported holding Hemab Therapeutics Holdings, Inc., 77.5% of its shares. Largest: Ra Capital Management, L.P., Novo Holdings A/S and Fidelity. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Hemab Therapeutics Holdings, Inc. | Change | Filed |
|---|---|---|---|---|
| Ra Capital Management, L.P. | 7.81M | 16.7% | new | Aug 14, 2026 |
| Novo Holdings A/S | 4.18M | 8.9% | new | Aug 14, 2026 |
| Fidelity | 3.7M | 7.9% | new | Aug 13, 2026 |
| Capital Group | 3.6M | 7.7% | new | Aug 12, 2026 |
| Deep Track Capital, LP | 3.6M | 7.7% | new | Aug 14, 2026 |
| Siren, L.L.C. | 2.09M | 4.5% | new | Aug 13, 2026 |
| Avoro Capital Advisors LLC | 1.93M | 4.1% | new | Aug 14, 2026 |
| Bain Capital Life Sciences Investors, LLC | 1.65M | 3.5% | new | Aug 14, 2026 |
| JPMorgan | 1.15M | 2.5% | new | Aug 12, 2026 |
| Vanguard | 909K | 1.9% | new | Aug 13, 2026 |